Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $214,434 - $240,002
-682 Reduced 54.39%
572 $201,000
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $1,699 - $1,938
6 Added 0.48%
1,254 $395,000
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $8,858 - $9,965
31 Added 2.55%
1,248 $360,000
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $73,934 - $82,493
270 Added 28.51%
1,217 $352,000
Q2 2022

Aug 11, 2022

BUY
$234.96 - $292.55 $222,507 - $277,044
947 New
947 $267,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.